CONSTANT LEVERAGE LONG - PFIZER INC | Market Closed - Euronext Paris 12:30:02 2024-05-17 pm EDT | ||
| 7.675 EUR | -2.17% |
|
| Current month | +34.95% | ||
| 1 month | +37.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 7.675 | -2.17% |
| 24-05-16 | 7.845 | -1.38% |
| 24-05-15 | 7.955 | +6.85% |
| 24-05-14 | 7.445 | -1.26% |
| 24-05-13 | 7.54 | +3.15% |
Real-time Euronext Paris
Last update May 17, 2024 at 12:30 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| UH6MB | |
| ISIN | NLBNPNL2M0G0 |
| Date issued | 2024-01-04 |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 9.14 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.41 € |
|---|---|
| Lowest since issue | 5.425 € |
| Spread | 0.05 € |
| Spread % | 0.65% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.92
USD
Average target price
31.94
USD
Spread / Average Target
+10.44%
- Stock Market
- Certificates
- UH6MB Certificat
